Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial
about
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial
description
scientific article published on 01 February 2019
@en
name
Paclitaxel with or without tra ...... sed, controlled phase II trial
@en
type
label
Paclitaxel with or without tra ...... sed, controlled phase II trial
@en
prefLabel
Paclitaxel with or without tra ...... sed, controlled phase II trial
@en
P2093
P356
P1433
P1476
Paclitaxel with or without tra ...... sed, controlled phase II trial
@en
P2093
D Schadendorf
E Marshall
M R Middleton
P304
P356
10.1093/ANNONC/MDY500
P577
2019-02-01T00:00:00Z